Brain-derived neurotrophic factor.

By D. Binder, H. Scharfman. Growth Factors, 2004

1,843 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Developmental Neuroscience

View Paper: https://www.semanticscholar.org/paper/e04003a4325c9f903301dd2ba05b20bfa15cc740

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cellular and Molecular Neuroscience

1. Peter J. Gianaros
2. David P. Finn
3. Bruce S. McEwen
4. Undurti N. Das
5. Mark P. Mattson
6. Michael E. Greenberg
7. Paul L. Greer
8. Siresha Bathina

In Developmental Neuroscience

1. Bruce S. McEwen
2. Peter J. Gianaros
3. Mark P. Mattson
4. Michael E. Greenberg
5. R. Duman
6. J. Wingfield
7. A. Beck
8. Keith Bredemeier

Citations in the corpus

• Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. (2008, background): “Yet another example is the consequence of having the Val66Met allele of the BDNF gene on hippocampal volume, memory and mood disorders (Hariri et al., 2003; Pezawas et al., 2004; Jiang et al., 2005; Szeszko et al., 2005).”
• From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. (2008, background): “…AMPA receptors (calcium permeable), while in the mature brain, GluR2-containing AMPA receptors (calcium impermeable) predominate, suggesting that during brain development different activity-dependent transcriptional programs may be induced than in the mature nervous system (Kumar et al., 2002).”
• The impact of physical activity on psychological health during Covid-19 pandemic in Italy (2020, positive): “BDNF, whose levels are upregulated following exercise, represents the most abundant neurotrophin in the brain, which positively influences both anxiety and depressive disorders [43].”
• Calcium and neurodegeneration (2007, background): “improves cognitive function in animal models relevant to AD (Bruce-Keller et al., 1999; Zhu et al., 1999; Duan et al., 2001; Patel et al., 2005; Wang et al., 2005a).”
• The effect of pain on cognitive function: a review of clinical and preclinical research. (2011, background): “to enhance neurogenesis (Binder and Scharfman, 2004), thought to be important for hippocampal-dependent learning and memory.”
• TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment (2008, methodology): “We have previously reported that conditional deletion of BDNF using the hGFAP-Cre transgene (BDNF) resulted in 80% reduction of BDNF protein level in the hippocampus (Monteggia et al., 2007); we note that these mice also displayed significantly reduced DG granular layer volume, indicating a ligand-r”
• Brain-derived neurotrophic factor and its clinical implications (2015, background): “Brain-derived neurotrophic factor (BDNF) is one of the neurotrophic factors that support differentiation [1], maturation [2], and survival of neurons in the nervous system [3] and shows a neuroprotective effect under adverse conditions, such as glutamatergic stimulation, cerebral ischemia, hypoglyce”
• Prospective reports of chronic life stress predict decreased grey matter volume in the hippocampus (2007, background): “…evidence, for example, shows that carriers of the methionine (met) allele of the valine(val)66met brain-derived neurotrophic factor (BDNF) polymorphism express lower grey matter volume in the hippocampus and prefrontal cortex compared with carriers of the val/val allele (Pezawas et al., 2004).”